| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.098 | 0.001 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |